Literature DB >> 26492480

Resolvin D1: A New Path to Unleash the Analgesic Potential of Peroxisome Proliferator-activated Receptor-γ for Postoperative Pain in Patients with Diabetes.

Bradley K Taylor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26492480      PMCID： PMC4679622          DOI： 10.1097/ALN.0000000000000893

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  10 in total

1.  PPARγ activation blocks development and reduces established neuropathic pain in rats.

Authors:  J Morgenweck; R B Griggs; R R Donahue; J E Zadina; B K Taylor
Journal:  Neuropharmacology       Date:  2013-02-13       Impact factor: 5.250

Review 2.  Emerging roles of resolvins in the resolution of inflammation and pain.

Authors:  Ru-Rong Ji; Zhen-Zhong Xu; Gary Strichartz; Charles N Serhan
Journal:  Trends Neurosci       Date:  2011-09-30       Impact factor: 13.837

3.  Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.

Authors:  Sajay B Churi; Omar S Abdel-Aleem; Kiranjeet K Tumber; Heather Scuderi-Porter; Bradley K Taylor
Journal:  J Pain       Date:  2008-04-03       Impact factor: 5.820

4.  Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-γ-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes.

Authors:  Takayuki Saito; Maiko Hasegawa-Moriyama; Tae Kurimoto; Tomotsugu Yamada; Eichi Inada; Yuichi Kanmura
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

5.  Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization.

Authors:  Maiko Hasegawa-Moriyama; Tetsuya Ohnou; Kohei Godai; Tae Kurimoto; Mayo Nakama; Yuichi Kanmura
Journal:  Biochem Biophys Res Commun       Date:  2012-08-14       Impact factor: 3.575

6.  Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.

Authors:  J Morgenweck; O S Abdel-Aleem; K C McNamara; R R Donahue; M Z Badr; B K Taylor
Journal:  Neuropharmacology       Date:  2009-11-03       Impact factor: 5.250

7.  Animal models of diabetes-induced neuropathic pain.

Authors:  Corinne A Lee-Kubli; Teresa Mixcoatl-Zecuatl; Corinne G Jolivalt; Nigel A Calcutt
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 8.  Rapid pain modulation with nuclear receptor ligands.

Authors:  Jill C Fehrenbacher; Jesse Loverme; William Clarke; Kenneth M Hargreaves; Daniele Piomelli; Bradley K Taylor
Journal:  Brain Res Rev       Date:  2008-12-31

9.  Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms.

Authors:  Ryan B Griggs; Renee R Donahue; Jenny Morgenweck; Peter M Grace; Amanda Sutton; Linda R Watkins; Bradley K Taylor
Journal:  Pain       Date:  2015-03       Impact factor: 7.926

10.  Proresolution therapy for the treatment of delayed healing of diabetic wounds.

Authors:  Yunan Tang; Michael J Zhang; Jason Hellmann; Madhavi Kosuri; Aruni Bhatnagar; Matthew Spite
Journal:  Diabetes       Date:  2012-10-05       Impact factor: 9.461
  10 in total
  2 in total

1.  Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.

Authors:  Ryan B Griggs; Renee R Donahue; Braxton G Adkins; Katie L Anderson; Olivier Thibault; Bradley K Taylor
Journal:  J Pain       Date:  2015-12-12       Impact factor: 5.820

Review 2.  Role of Resolvins in the Inflammatory Resolution of Neurological Diseases.

Authors:  Chunrong Li; Xiujuan Wu; Shan Liu; Donghui Shen; Jie Zhu; Kangding Liu
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.